Clear Harbor Asset Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Clear Harbor Asset Management’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-243,671	Closed	-$283K	–	429
2022 Q2	$283K	Buy	243,671 +95,194	+64%	+$99.5K	0.04%	279
2022 Q1	$160K	Buy	148,477 +72,800	+96%	+$55K	0.02%	356
2021 Q4	$55K	Buy	75,677 +22,027	+41%	+$17.8K	0.01%	399
2021 Q3	$48K	Hold	53,650	–	–	﹤0.01%	377
2021 Q2	$89K	Sell	53,650 -6,304	-11%	-$10.5K	0.01%	356
2021 Q1	$125K	Sell	59,954 -12,250	-17%	-$25.4K	0.02%	322
2020 Q4	$90K	Buy	+72,204	New	+$86.1K	0.01%	294

Clear Harbor Asset Management's MBII Position: Q3 2022 in Review

Clear Harbor Asset Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 243,671 shares — an estimated $283K sold.

Clear Harbor Asset Management first reported a position in MBII in Q4 2020 and held it in 7 quarters. The position peaked at $283K in Q2 2022. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

Clear Harbor Asset Management reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
Clear Harbor Asset Management sold 243,671 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $283K.
Clear Harbor Asset Management first reported a position in Marrone Bio Innovations, Inc. in Q4 2020 and held it in 7 quarters.
Clear Harbor Asset Management's Marrone Bio Innovations, Inc. position peaked at $283K in Q2 2022.
0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Clear Harbor Asset Management's 13F filing for Q3 2022, filed 25 Oct 2022.